|
|
PRESS RELEASE: Pharmaceutical Compliance Forum's Fourteenth Pharmaceutical Regulatory Compliance Congress Features Nat Edmonds, Esq. & Lew Morris, Esq.
- Sponsored by the Pharmaceutical Compliance Forum
- October 28 - 30, 2013
- Onsite at Hyatt Regency on Capitol Hill, Washington, DC
- Online in Your Own Office or Home Live via the Internet with 24/7 Access for Six Months
- www.PharmaCongress.com
PRESS RELEASE
Phone: 800-503-7419
Email: registration@hcconferences.com
Website: www.PharmaCongress.com |
FEATURING LESSONS LEARNED FROM
PUBLIC SERVICE BY:
|
 |
Nathaniel B. Edmonds, Esq., Partner, Paul Hastings, Former Assistant Chief, Foreign Corrupt Practices Act Unit, Fraud Section, Criminal Division, US Department of Justice, Washington, DC
|
 |
Lewis Morris, Esq., Senior Counsel, Adelman, Sheff and Smith LLC, Former Chief Counsel to the Inspector General, Office of Inspector General, US Department of Health and Human Services, Annapolis, MD
|
 |
Ted Acosta, Esq., Principal, Ernst & Young LLP, Former Senior Counsel, Office of Inspector General, US Department of Health and Human Services, New York, NY and Paris, France (Moderator)
|
|
|
|
WASHINGTON DC USA -- PHARMA UPDATE NEWS SERVICE™ -- JULY 15, 2013: The Fourteenth Annual Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum (the Pharma Congress), www.PharmaCongress.com, will take place on October 28-30, 2013 at the Hyatt Regency on Capitol Hill in Washington, DC. Registrants may attend the event in person or online (live webcast and archived for 6 months).
|
|
CO CHAIRS
|
Gary DelVecchio
Executive Director, US Pharmaceutical Compliance and Ethics, Bristol-Myers Squibb Company, Plainsboro, NJ |
Margaret K. Feltz, Esq.
Director, Corporate Compliance, Purdue Pharma LP, Stamford, CT
|
Kelly B. Freeman, PhD
Senior Director, Ethics and Compliance, Eli Lilly and Company, Indianapolis, IN |
Elizabeth V. Jobes, Esq.
Senior Vice President, Chief Compliance Officer, Auxilium Pharmaceuticals Inc., Philadelphia, PA
|
|
|
|
FEATURED FACULTY
|
Thomas W. Abrams, RPh, MBA
Director, Division of Drug Marketing, Advertising, and Communications, Center for Drug Evaluation and Research CDER), Food and Drug Administration, Silver Spring, MD |
Ted Acosta, Esq.
Principal, Ernst & Young LLP, Former Senior Counsel, Office of Inspector General, US Department of Health and Human Services, New York, NY and Paris, France |
Mary Bennett
Vice President Advisory Services, Ethical Leadership Group™, The Advisory Services Practice of NAVEX Global, Former Vice President of the Compliance, and Integrity Group, Caremark, Mundelein, IL
|
John T. Bentivoglio, Esq.
Partner, Skadden Arps LLP, Former Special Counsel for Healthcare Fraud and Chief Privacy Officer, US Department of Justice, Washington, DC |
Jan Byars, PhD
Founder and President, LeadSync, LLC, Co-Chair, Ethics Forum Learning Community, Vandalia, OH |
Scott A. Coffina, Esq.
Partner, Drinker Biddle & Reath LLP, Former Associate Counsel to President George W. Bush, Former Assistant US Attorney, Philadelphia, PA
|
Nathaniel B. Edmonds, Esq.
Partner, Paul Hastings, Former Assistant Chief, Foreign Corrupt Practices Act Unit, Fraud Section, Criminal Division, US Department of Justice, Washington, DC |
Sue Egan
Director and Principal Consultant, Sue Egan Associates, Former Vice President Compliance, AstraZeneca, Great Missenden, Buckinghamshire, UK |
Todd Evans
Director, PricewaterhouseCoopers LLP, Pharmaceutical & Life Sciences Advisory, Chicago, IL
|
Thomas M. Gallagher, Esq.
Partner and Chair, White Collar and Corporate, Investigations Practice Group, Pepper Hamilton LLP, Philadelphia, PA |
Gary F. Giampetruzzi, Esq.
Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc., New York, NY |
Wendy C. Goldstein, Esq.
Partner, Health Care & Life Sciences Regulatory Practice, Cooley, LLP, New York, NY
|
Peter Harries, MBA
Partner, Health Information & Privacy Advisory, PricewaterhouseCoopers LLP, Los Angeles, CA |
Jonathon Kellerman
Principal, Pharmaceutical and Life Sciences Advisory Services, PricewaterhouseCoopers LLP, Florham Park, NJ |
Lewis Morris, Esq.
Senior Counsel, Adelman, Sheff and Smith LLC, Former Chief Counsel to the Inspector General, Office of Inspector General, US Department of Health and Human Services, Annapolis, MD
|
Maxine Nogard, MBA
Senior Director, Corporate Compliance, Biogen Idec, Inc., Weston, MA |
Joshua Pagliaro
Director, PricewaterhouseCoopers LLP, Pharmaceutical & Life Sciences Advisory, Chicago, IL |
Donna Phelps
Product Specialist, Advisory Service, Navex Global, Former Senior Director of Corporate Compliance, Biogen Idec, Lake Oswega, OR
|
Paula J. Presnoples, MPA, SPHR
Consultant, LeadSync, LLC, Vandalia, OH |
Janet L. "Lucy" Rose
President, Lucy Rose and Associates, LLC, Former Director, FDA Division of Drug Marketing, Advertising, and Communications (DDMAC), Former Director, FDA Office of Training and Communications, Center for Drug Evaluation and Research (CDER), Washington, DC |
William A. Sarraille, Esq.
Partner, Sidley Austin LLP, Washington, DC
|
Michael L. Shaw, Esq.
Vice President and Compliance Officer, GlaxoSmithKline-NA Pharmaceuticals, Former Senior Counsel, Office of Inspector General, US Department of Health and Human Services, Philadelphia, PA |
Paul J. Silver
Managing Director, Huron Consulting Group, Atlanta, GA
|
Jack T. Tanselle
Director, Healthcare Dispute Compliance, and Investigation Practice, Navigant Consulting, Inc., Indianapolis, IN |
Matthew Yesko, CPLP
Senior Consultant, Aquinas Leadership Group, Raleigh-Durham, NC
|
|
|
|
PCF PHARMA CONGRESS PLANNING COMMITTEE
|
Gary DelVecchio
Executive Director, US Pharmaceutical Compliance and Ethics, Bristol-Myers Squibb Company (Co chair)
Margaret K. Feltz
Director, Corporate Compliance, Purdue Pharma LP (Co chair)
Kelly B. Freeman, PhD
Senior Director, Ethics and Compliance, Eli Lilly and Company (Co chair)
Elizabeth V. Jobes, Esq.
Senior Vice President, Chief Compliance Officer, Auxilium Pharmaceuticals Inc. (Co chair)
Ted Acosta, Esq.
Principal, Ernst & Young LLP
Karen Anderson
Chief Compliance Officer, Cubist Pharmaceuticals Inc.
Timothy Ayers, Esq.
Compliance Consulting
Wayne Baker
Senior Vice President and Chief Sales Officer, AHM
Valli Baldassano
President and CEO, VFB Associates, PC
Scott Bass, Esq.
Partner, Sidley Austin LLP
John T. Bentivoglio, Esq.
Partner, Skadden Arps LLP
Eve M. Brunts, Esq.
Partner, Ropes & Gray
Eve Costopoulos
Vice President, Chief Ethics & Compliance Officer, Eisai Inc.
Sujata T. Dayal
Corporate Vice President and Chief Compliance Officer, Global Operations, Biomet, Inc.
Michael B. Dusseau
Divisional Compliance Officer, Merck Consumer Care
Keary Dunn, Esq.
Global Head, Ethics and Compliance, Novartis Oncology
Sue Egan
Director and Principal Consultant, Sue Egan Associates
Thomas Forrester, Esq.
Vice President, US Legal Affairs and General Counsel, Lundbeck Inc.
Thomas M. Gallagher, Esq.
Partner and Chair, White Collar and Corporate Investigations Practice Group, Pepper Hamilton LLP
Steven N. Gersten, Esq.
Vice President and Ethics & Compliance Officer, AbbVie
Gary F. Giampetruzzi, Esq.
Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc.
Wendy C. Goldstein, Esq.
Partner, Cooley, LLP
Alessandra N. Hawthorne
Vice President, Chief Ethics and Compliance Officer, Boehringer Ingelheim USA, Inc.
Michael Hercz, Esq.
Director, Audit and Enterprise Risk Services, Deloitte & Touche LLP
|
|
Jonathan Kellerman
Partner, Global Pharmaceutical Advisory Services Group, PricewaterhouseCoopers LLP
Daniel Kracov, Esq.
Partner, Arnold & Porter LLP
Maxine Nogard
Senior Director, Global Corporate Compliance, Biogen Idec, Inc.
John Patrick Oroho, Esq.
Executive Vice President and, Chief Strategy Officer, Porzio Pharmaceutical Services, LLC; Principal, Porzio, Bromberg & Newman
Neena M. Patil, Esq.
Senior Corporate Counsel, Novo Nordisk Inc.
Lawrence P. Platkin
Vice President and Compliance Officer, Bayer Healthcare LLC
Kelly N. "Nikki" Reeves, MPA, JD
Partner, King & Spalding LLP
Lynn Robson, Esq.
Executive Director, Legal and Compliance, LEO Pharma Inc.
Susan Romanus
Vice President, Chief Ethics & Compliance Officer, Daiichi Sankyo
Jeff Rosenbaum
Vice President, Chief Compliance Officer, Vertex Pharmaceuticals
Michael L. Shaw, Esq.
Vice President & Compliance Officer, GlaxoSmithKline-NA Pharmaceuticals
Karen Patruno Sheehy, Esq.
Vice President, US Corporate Compliance Officer, Sanofi
Eric Siegel, Esq.
Executive Vice President & General Counsel, Incyte Corporation
Paul J. Silver
Managing Director, Huron Consulting Group
Jon Smollen, Esq.
Executive Vice President and Chief Compliance Officer, Endo Pharmaceuticals Inc.
Don Soong
Vice President of Strategic Solutions, Cegedim Relationship Management, Richmond, VA
Jack T. Tanselle
Managing Director, Navigant Consulting, Inc.
Mike Wagner, Esq.
Partner and Chair, Global and North America Pharma Industry Groups, Baker & McKenzie
Caroline West, Esq.
Senior Vice President, Chief Compliance and Risk Officer, Shire Pharmaceuticals, Inc.
Ronald L. Wisor, Jr., Esq.
Partner, Hogan Lovells US LLP
Christopher D. Zalesky
Executive Director, World Wide Office of Health Care Compliance & Privacy, Johnson & Johnson
Richard L. Zimmerer
Partner, Forensic Advisory Services, KPMG LLP
|
|
|
|
|
|
SPEAKER PRESENTATION PROPOSALS DUE BY JULY 19
|
Speaker/Presentation Proposals for the Fourteenth Pharma Congress May Be Submitted Through Our Online Form
- Click Here -
|
|
|
|
|
SPONSORED BY:
|
The Pharmaceutical Compliance Forum (PCF) is a coalition of senior compliance professionals and legal counsel from more than 50 of the largest research-based pharmaceutical manufacturers. The PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry to promote effective corporate compliance programs. The members meet twice a year, for two days, focusing on open and informal sharing of compliance information, best practices, and current developments in the field, and sponsors a two-day international compliance congress in the Spring and a three-day US compliance congress each Fall.
|
|
GRANTORS:
|
|
SILVER
|
|
|
BRONZE
|
|
|
MEDIA PARTNERS:
|
|
|
PAST GLOBAL PHARMA CONGRESS CITIES
|
Washington, DC
Brussels
Paris
Rome
Berlin
Istanbul
Singapore
2012 - Budapest, Hungary
2012 - Shanghai, China
2012 - São Paulo, Brazil
2013 - Madrid, Spain
|
|
FOLLOW PHARMA CONGRESS ON
|
|
|
|
SAVE THE DATES
|
|
THIRD ASIA PACIFIC
PHARMACEUTICAL COMPLIANCE
CONGRESS
|
A Hybrid Conference and Internet Event
Sponsored by Asia Pacific Healthcare Industry Compliance Team
Cosponsored by Pharmaceutical Compliance Forum
September 10 - 12, 2013
Kuala Lampur, Malaysia
www.AsianPharmaCongress.com
|
|
FOURTEENTH PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS
|
A Hybrid Conference and Internet Event
Sponsored by Pharmaceutical Compliance Forum
October 28 - 30, 2013
Hyatt Regency on Capitol Hill
Washington, DC
www.PharmaCongress.com
|
|
SIXTH ANNUAL SUMMIT ON DISCLOSURE, TRANSPARENCY AND AGGREGATE SPEND FOR DRUG, DEVICE AND BIOTECH COMPANIES
|
A Hybrid Conference and Internet Event
February 5 - 7, 2014
Hyatt Regency Crystal City
Washington, DC
www.DisclosureSummit.com
|
|
|
|
